{"id": 1365398732699820036, "geo": null, "lang": "en", "text": "RT @PHEgov: \ud83c\udd95@BARDA &amp; @JPEOCBRND worked together to purchase 100,000 treatment courses of a second @LillyPad monoclonal antibody medicine r\u2026", "user": {"id": 44783853, "url": "http://www.hhs.gov", "lang": null, "name": "HHS.gov", "id_str": "44783853", "location": "Washington, D.C.", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Fri Jun 05 01:14:31 +0000 2009", "utc_offset": null, "description": "News and information from the U.S. Department of Health & Human Services (HHS). Privacy policy: https://www.hhs.gov/privacy.html.", "geo_enabled": true, "screen_name": "HHSGov", "listed_count": 9476, "friends_count": 336, "is_translator": false, "notifications": null, "statuses_count": 23501, "default_profile": false, "followers_count": 1065606, "translator_type": "none", "favourites_count": 4210, "profile_image_url": "http://pbs.twimg.com/profile_images/567350542326718464/FXOsgyA7_normal.jpeg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/44783853/1609771062", "profile_link_color": "5FA9C2", "profile_text_color": "050505", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/567350542326718464/FXOsgyA7_normal.jpeg", "profile_background_color": "0F5BB1", "profile_sidebar_fill_color": "185293", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "F9FAF3", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1365398732699820036", "source": "<a href=\"https://prod1.sprinklr.com\" rel=\"nofollow\">Sprinklr Publishing</a>", "entities": {"urls": [], "symbols": [], "hashtags": [], "user_mentions": [{"id": 137450696, "name": "ASPR", "id_str": "137450696", "indices": [3, 10], "screen_name": "PHEgov"}, {"id": 855482932173168640, "name": "BARDA", "id_str": "855482932173168640", "indices": [13, 19], "screen_name": "BARDA"}, {"id": 461174259, "name": "JPEO-CBRND", "id_str": "461174259", "indices": [26, 36], "screen_name": "JPEOCBRND"}, {"id": 172496840, "name": "Eli Lilly and Company", "id_str": "172496840", "indices": [103, 112], "screen_name": "LillyPad"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Fri Feb 26 20:30:00 +0000 2021", "coordinates": null, "quote_count": 0, "reply_count": 0, "contributors": null, "filter_level": "low", "timestamp_ms": "1614371400414", "retweet_count": 0, "favorite_count": 0, "is_quote_status": false, "retweeted_status": {"id": 1365274442864205825, "geo": null, "lang": "en", "text": "\ud83c\udd95@BARDA &amp; @JPEOCBRND worked together to purchase 100,000 treatment courses of a second @LillyPad monoclonal antibod\u2026 https://t.co/VKP2LZJPOn", "user": {"id": 137450696, "url": "http://www.phe.gov", "lang": null, "name": "ASPR", "id_str": "137450696", "location": "Washington, DC", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Mon Apr 26 19:58:30 +0000 2010", "utc_offset": null, "description": "http://PHE.gov provides information on disaster health preparedness, response & recovery. Brought to you by HHS/ASPR. Privacy: http://phe.gov/privacy", "geo_enabled": false, "screen_name": "PHEgov", "listed_count": 619, "friends_count": 194, "is_translator": false, "notifications": null, "statuses_count": 9719, "default_profile": false, "followers_count": 18091, "translator_type": "none", "favourites_count": 223, "profile_image_url": "http://pbs.twimg.com/profile_images/849301903372673024/hMhvyZPl_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/137450696/1602622989", "profile_link_color": "5891C9", "profile_text_color": "333333", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/849301903372673024/hMhvyZPl_normal.jpg", "profile_background_color": "0265C7", "profile_sidebar_fill_color": "DCEDEC", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "12DFFF", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1365274442864205825", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/VKP2LZJPOn", "indices": [121, 144], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1365274442864205825"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 855482932173168640, "name": "BARDA", "id_str": "855482932173168640", "indices": [1, 7], "screen_name": "BARDA"}, {"id": 461174259, "name": "JPEO-CBRND", "id_str": "461174259", "indices": [14, 24], "screen_name": "JPEOCBRND"}, {"id": 172496840, "name": "Eli Lilly and Company", "id_str": "172496840", "indices": [91, 100], "screen_name": "LillyPad"}]}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Fri Feb 26 12:16:07 +0000 2021", "coordinates": null, "quote_count": 0, "reply_count": 0, "contributors": null, "filter_level": "low", "retweet_count": 1, "extended_tweet": {"entities": {"urls": [{"url": "https://t.co/42oXi80vwJ", "indices": [241, 264], "display_url": "phe.gov/Preparedness/n\u2026", "expanded_url": "https://www.phe.gov/Preparedness/news/Pages/COVID-etesevimab.aspx"}], "media": [{"id": 1365274366481731585, "url": "https://t.co/OZ6mWqSTSF", "type": "photo", "sizes": {"large": {"h": 492, "w": 983, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 492, "w": 983, "resize": "fit"}}, "id_str": "1365274366481731585", "indices": [265, 288], "media_url": "http://pbs.twimg.com/media/EvJtzYMXEAEv2mo.jpg", "display_url": "pic.twitter.com/OZ6mWqSTSF", "expanded_url": "https://twitter.com/PHEgov/status/1365274442864205825/photo/1", "media_url_https": "https://pbs.twimg.com/media/EvJtzYMXEAEv2mo.jpg"}], "symbols": [], "hashtags": [{"text": "COVID19", "indices": [190, 198]}], "user_mentions": [{"id": 855482932173168640, "name": "BARDA", "id_str": "855482932173168640", "indices": [1, 7], "screen_name": "BARDA"}, {"id": 461174259, "name": "JPEO-CBRND", "id_str": "461174259", "indices": [14, 24], "screen_name": "JPEOCBRND"}, {"id": 172496840, "name": "Eli Lilly and Company", "id_str": "172496840", "indices": [91, 100], "screen_name": "LillyPad"}, {"id": 208120290, "name": "U.S. FDA", "id_str": "208120290", "indices": [153, 160], "screen_name": "US_FDA"}]}, "full_text": "\ud83c\udd95@BARDA &amp; @JPEOCBRND worked together to purchase 100,000 treatment courses of a second @LillyPad monoclonal antibody medicine recently issued EUA by @US_FDA to treat mild &amp; moderate #COVID19 patients at high risk of hospitalization. https://t.co/42oXi80vwJ https://t.co/OZ6mWqSTSF", "extended_entities": {"media": [{"id": 1365274366481731585, "url": "https://t.co/OZ6mWqSTSF", "type": "photo", "sizes": {"large": {"h": 492, "w": 983, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 492, "w": 983, "resize": "fit"}}, "id_str": "1365274366481731585", "indices": [265, 288], "media_url": "http://pbs.twimg.com/media/EvJtzYMXEAEv2mo.jpg", "display_url": "pic.twitter.com/OZ6mWqSTSF", "expanded_url": "https://twitter.com/PHEgov/status/1365274442864205825/photo/1", "media_url_https": "https://pbs.twimg.com/media/EvJtzYMXEAEv2mo.jpg"}]}, "display_text_range": [0, 264]}, "favorite_count": 1, "is_quote_status": false, "display_text_range": [0, 140], "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}